Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tradjenta Indicated for the Treatment of Type II Diabetes

Linagliptin (BI-1356) is an oral DPP-4 inhibitor drug for the treatment of type-II diabetes.

Go Top